Go Pro
NASDAQ:JYNT

Joint (JYNT) Stock Price, News & Analysis

Joint logo
$8.72 +0.09 (+1.08%)
As of 02:37 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Joint Stock (NASDAQ:JYNT)

Advanced

Key Stats

Today's Range
$8.39
$8.73
50-Day Range
$8.20
$9.58
52-Week Range
$7.50
$11.26
Volume
47,903 shs
Average Volume
81,801 shs
Market Capitalization
$124.35 million
P/E Ratio
32.31
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

The Joint Chiropractic, Inc., doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.

Joint’s growth strategy centers on partnering with franchisees to expand its network of clinics. Since its founding in 1999, the company has opened over 700 locations across more than 25 states, serving a diverse customer base of both first-time and long-term patients. Joint employs standardized training programs, proprietary care protocols and technology-driven scheduling systems to ensure consistent service quality and operational efficiency across its franchise system.

Headquartered in Scottsdale, Arizona, Joint completed its initial public offering in late 2021, transitioning from a privately held franchisor to a publicly traded company. The business was founded by chiropractor Peter D. Holt, who continues to serve as Chief Executive Officer, overseeing national expansion efforts. With a focus on digital marketing, patient retention and incremental clinic growth, Joint seeks to capture a larger share of the growing U.S. chiropractic services market.

AI Generated. May Contain Errors.

Joint Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

JYNT MarketRank™: 

Joint scored higher than 62% of companies evaluated by MarketBeat, and ranked 322nd out of 902 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Joint has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Joint has only been the subject of 2 research reports in the past 90 days.

  • Read more about Joint's stock forecast and price target.
  • Earnings Growth

    Earnings for Joint are expected to grow by 25.49% in the coming year, from $0.51 to $0.64 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Joint is 32.31, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.47.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Joint is 32.31, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 268.68.

  • Price to Book Value per Share Ratio

    Joint has a P/B Ratio of 8.64. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    4.75% of the float of Joint has been sold short.
  • Short Interest Ratio / Days to Cover

    Joint has a short interest ratio ("days to cover") of 4.47.
  • Change versus previous month

    Short interest in Joint has recently increased by 0.33%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Joint does not currently pay a dividend.

  • Dividend Growth

    Joint does not have a long track record of dividend growth.

  • News Sentiment

    Joint has a news sentiment score of 0.66. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Joint this week, compared to 2 articles on an average week.
  • Net Insider Buying

    Over the last three months, insiders have purchased a net $1,094,183.00 in company stock, which represents 0.8799% of the company's market cap.

  • Insider Buying vs. Insider Selling

    In the past three months, Joint insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,094,183.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    30.20% of the stock of Joint is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    76.88% of the stock of Joint is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Joint's insider trading history.
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

JYNT Stock News Headlines

Joint (NASDAQ:JYNT) Upgraded by Wall Street Zen to "Strong-Buy" Rating
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
The Joint Corp. (JYNT) Q2 2026 Earnings Call Transcript
See More Headlines

JYNT Stock Analysis - Frequently Asked Questions

Joint's stock was trading at $8.72 at the beginning of the year. Since then, JYNT stock has increased by 0.0% and is now trading at $8.7230.

The Joint Corp. (NASDAQ:JYNT) announced its quarterly earnings data on Thursday, August, 6th. The company reported $0.05 earnings per share for the quarter, beating analysts' consensus estimates of $0.05 by $0.00. The company had revenue of $15.18 million for the quarter, compared to the consensus estimate of $14.57 million. Joint had a trailing twelve-month return on equity of 12.02% and a net margin of 6.49%.
Read the conference call transcript
.

Joint's board initiated a stock buyback plan on Thursday, June 5th 2025, which allows the company to buy back $5,000,000 in shares, according to EventVestor. This means that the company could purchase up to 2.7% of its stock through open market purchases. Stock buyback plans are usually a sign that the company's board of directors believes its stock is undervalued.

Joint (JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.00-$7.00 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

Top institutional investors of Joint include BlackRock Inc. (2.02%). Insiders that own company stock include Bandera Partners Llc and Christopher M Grandpre.
View institutional ownership trends
.

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Joint investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
8/06/2026
Today
8/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:JYNT
CIK
1612630
Employees
320
Year Founded
1999

Profitability

EPS (Trailing Twelve Months)
$0.27
Trailing P/E Ratio
32.31
Forward P/E Ratio
17.10
P/E Growth
N/A
Net Income
$2.91 million
Net Margins
6.49%
Pretax Margin
3.61%
Return on Equity
12.02%
Return on Assets
3.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.83
Quick Ratio
1.64

Sales & Book Value

Annual Sales
$58.55 million
Price / Sales
2.12
Cash Flow
$0.10 per share
Price / Cash Flow
85.64
Book Value
$1.01 per share
Price / Book
8.64

Miscellaneous

Outstanding Shares
14,255,000
Free Float
9,950,000
Market Cap
$124.35 million
Optionable
Optionable
Beta
1.10

Social Links

(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:JYNT) was last updated on 8/11/2026 by MarketBeat.com Staff.
From Our Partners